Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids

被引:200
作者
Xiao, YJ
Schwartz, B
Washington, M
Kennedy, A
Webster, K
Belinson, J
Xu, Y
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Lerner Res Inst, Dept Gynecol & Obstet, Cleveland, OH 44195 USA
关键词
D O I
10.1006/abio.2001.5000
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Lysophospholipids (lyso-PLs), including various glycerol-based and sphingosine-based lysophospholipids, play important roles in many biochemical, physiological, and pathological processes. The classical methods to analyze these Lipids involve gas chromatography and/or high-performance liquid chromatography, which are time-consuming, cumbersome, and sometimes inaccurate due to the incomplete separation of closely related lipid species. We now describe the quantitative analysis of lyso-PLs in ascites samples from patients with ovarian cancer using electrospray ionization spectrometry. Three new classes of lyso-PL molecules are detected: nUrvl-LPA, alkenyl-LPA, and methylated lysophosphatidylethanolamine. Importantly, the following lysophospholipid species are significantly increased in ascites from patients with ovarian cancer, compared to patients with nonmalignant diseases (e.g., Liver failure): LPA (including acyl-, Alkyl-, and alkenyl-LPA species), lysophosphatidylinositol, and sphingosylphosphorylcholine. Lysophosphorylcholine contents are also significantly different among ascitic fluids from the two groups of patients. However, the total phosphate content in ascites samples from patients with ovarian cancer is not significantly different compared to that from patients with nonmalignant disease. (C) 2001 Academic Press.
引用
收藏
页码:302 / 313
页数:12
相关论文
共 28 条
[11]   ASCITIC FLUID FROM HUMAN OVARIAN-CANCER PATIENTS CONTAINS GROWTH-FACTORS NECESSARY FOR INTRAPERITONEAL GROWTH OF HUMAN OVARIAN ADENOCARCINOMA CELLS [J].
MILLS, GB ;
MAY, C ;
HILL, M ;
CAMPBELL, S ;
SHAW, P ;
MARKS, A .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :851-855
[12]  
MILLS GB, 1988, CANCER RES, V48, P1066
[13]  
Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1
[14]   Lysophosphatidic acid: G-protein signalling and cellular responses [J].
Moolenaar, WH ;
Kranenburg, O ;
Postma, FR ;
Zondag, GCM .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :168-173
[15]   ALTERATION IN PHOSPHOLIPID METHYLATION AND IMPAIRMENT OF SIGNAL TRANSMISSION IN PERSISTENTLY PARAMYXOVIRUS-INFECTED C6 RAT GLIOMA-CELLS [J].
MUNZEL, P ;
KOSCHEL, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (12) :3692-3696
[16]   METABOLISM OF PHOSPHOLIPIDS AND LYSOPHOSPHOLIPIDS BY TRYPANOSOMA-BRUCEI [J].
SAMAD, A ;
LICHT, B ;
STALMACH, ME ;
MELLORS, A .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1988, 29 (2-3) :159-169
[17]   HUMAN-PLATELET AGGREGATION INDUCED BY 1-ALKYL-LYSOPHOSPHATIDIC ACID AND ITS ANALOGS - A NEW GROUP OF PHOSPHOLIPID MEDIATORS [J].
SIMON, MF ;
CHAP, H ;
DOUSTEBLAZY, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (04) :1743-1750
[18]   Sphingosine 1-phosphate: a prototype of a new class of second messengers [J].
Spiegel, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (03) :341-344
[19]   Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells [J].
Sugiura, T ;
Nakane, S ;
Kishimoto, S ;
Waku, K ;
Yoshioka, Y ;
Tokumura, A ;
Hanahan, DJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1440 (2-3) :194-204
[20]   Signaling responses to alkyllysophosphatidic acid: The activation of phospholipases A(2) and C and protein tyrosine phosphorylation in human platelets' [J].
Svetlov, SI ;
SiafakaKapadai, A ;
Hanahan, DJ ;
Olson, MS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 336 (01) :59-68